AKT1 and hepatocellular carcinoma: The key output of their collaborative research was the finding that the activation of PI3K-AKT pathway can lead to the growth of liver cancer or colorectal cancer cells 20, as well as the proliferation of hepatocellular carcinoma (HCC) cells 21.